BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2335447)

  • 1. Responsiveness of retinoblastoma to local diaziquone. Studies in a xenograft model.
    White L
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):787-91. PubMed ID: 2335447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cyclophosphamide and diaziquone in a retinoblastoma xenograft model.
    White L; Reed C; Tobias V
    Ophthalmic Paediatr Genet; 1989 Jun; 10(2):99-105. PubMed ID: 2779985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue concentrations of doxorubicin in animal models with engrafted intraocular tumours.
    White L; Chan KK; Barrientos A; Gomer CJ; Murpheree AL; Benedict WF
    In Vivo; 1989; 3(5):315-7. PubMed ID: 2519871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of response to chemotherapy in retinoblastoma heterotransplanted to the eyes of nude mice.
    White L; Szirth BC; Benedict WF
    Cancer Chemother Pharmacol; 1989; 23(2):63-7. PubMed ID: 2910512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
    Schold SC; Friedman HS; Bjornsson TD; Bigner DD
    Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in retinoblastoma: current status and future directions.
    White L
    Am J Pediatr Hematol Oncol; 1991; 13(2):189-201. PubMed ID: 2069230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterotransplantation of retinoblastoma into the athymic "nude" mouse.
    Gallie BL; Albert DM; Wong JJ; Buyukmihci N; Pullafito CA
    Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):256-9. PubMed ID: 844983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat.
    Moore DJ; Powis G; Richardson RL; Pittelkow MR
    Cancer Res; 1985 Nov; 45(11 Pt 1):5466-72. PubMed ID: 4053022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality treatment using radiation and/or chemotherapy in an athymic nude mouse-human medulloblastoma and glioblastoma xenograft model.
    Slagel DE; Feola J; Houchens DP; Ovejera AA
    Cancer Res; 1982 Mar; 42(3):812-6. PubMed ID: 7059979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
    Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
    Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model.
    White L; Sterling-Levis K; Kees UR; Tobias V
    J Clin Neurosci; 2001 Mar; 8(2):151-6. PubMed ID: 11484666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
    Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma.
    Albert DM; Marcus DM; Gallo JP; O'Brien JM
    Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2354-64. PubMed ID: 1634333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does chemotherapy have a role in the treatment of retinoblastomas?].
    Campinchi R; Lemerle J; Bloch-Michel E; Pinget T; Schweisguth O; Luker P; Schlienger E; Chassagne A; Barret F
    Bull Soc Ophtalmol Fr; 1976 Jan; 76(1):17-22. PubMed ID: 1000747
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I-II diaziquone chemotherapy in brain tumors.
    Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
    Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heterotransplantation of the SO-Rb50 cell line into athymic "nude" mice].
    Feng GG; Li YP; Yi YZ
    Zhonghua Yan Ke Za Zhi; 1994 Jan; 30(1):47-9. PubMed ID: 8082477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo.
    Howard MA; Wardwell S; Albert DM
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1711-3. PubMed ID: 2032794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local carboplatin therapy in transgenic murine retinoblastoma.
    Harbour JW; Murray TG; Hamasaki D; Cicciarelli N; Hernández E; Smith B; Windle J; O'Brien JM
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1892-8. PubMed ID: 8759359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.